This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2003;42(7):619-31.

doi: 10.2165/00003088-200342070-00002.

Clinical pharmacokinetics of aromatase inhibitors and inactivators

Affiliations

PMID: 12844324
DOI: 10.2165/00003088-200342070-00002

Review

Clinical pharmacokinetics of aromatase inhibitors and inactivators

Per Lønning. Clin Pharmacokinet. 2003.

. 2003;42(7):619-31.

doi: 10.2165/00003088-200342070-00002.

Author

Affiliation

¹ Section of Oncology, Department of Medicine, University of Bergen, Haukeland University Hospital, Bergen, Norway. per.lonning@helse-bergen.no

PMID: 12844324
DOI: 10.2165/00003088-200342070-00002

No abstract available

PubMed Disclaimer

Similar articles

The effect of maraviroc on the pharmacokinetics of digoxin in healthy volunteers.
Vourvahis M, Fang J, Choo HW, Heera J. Vourvahis M, et al. Clin Pharmacol Drug Dev. 2014 May;3(3):202-6. doi: 10.1002/cpdd.91. Epub 2014 Feb 6. Clin Pharmacol Drug Dev. 2014. PMID: 27128610 Clinical Trial. No abstract available.
Interactions of antioestrogens and aromatase inhibitors.
Schmid P, Possinger K. Schmid P, et al. Forum (Genova). 2002;12(1):45-59. Forum (Genova). 2002. PMID: 12634910 Review.
Are differences in the available aromatase inhibitors and inactivators significant?
Johnson PE, Buzdar A. Johnson PE, et al. Clin Cancer Res. 2001 Dec;7(12 Suppl):4360s-4368s; discussion 4411s-4412s. Clin Cancer Res. 2001. PMID: 11916226 Review.
Aromatase inhibitors and inactivators for breast cancer therapy.
Lønning PE. Lønning PE. Drugs Aging. 2002;19(4):277-98. doi: 10.2165/00002512-200219040-00003. Drugs Aging. 2002. PMID: 12038879 Review.
Influence of cholestyramine on the pharmacokinetics of cerivastatin.
Mück W, Ritter W, Frey R, Wetzelsberger N, Lücker PW, Kuhlmann J. Mück W, et al. Int J Clin Pharmacol Ther. 1997 Jun;35(6):250-4. Int J Clin Pharmacol Ther. 1997. PMID: 9208341 Clinical Trial.

See all similar articles

Cited by

Sex-dependent effects of multiple acute concurrent stresses on memory: a role for hippocampal estrogens.
Hokenson RE, Alam YH, Short AK, Jung S, Jang C, Baram TZ. Hokenson RE, et al. Front Behav Neurosci. 2022 Sep 8;16:984494. doi: 10.3389/fnbeh.2022.984494. eCollection 2022. Front Behav Neurosci. 2022. PMID: 36160685 Free PMC article.
Letrozole: a review of its use in postmenopausal women with breast cancer.
Simpson D, Curran MP, Perry CM. Simpson D, et al. Drugs. 2004;64(11):1213-30. doi: 10.2165/00003495-200464110-00006. Drugs. 2004. PMID: 15161328 Review.
Clinical Efficacy, Pharmacokinetics, and Safety of the Available Medical Options in the Treatment of Endometriosis-Related Pelvic Pain: A Scoping Review.
Mikuš M, Šprem Goldštajn M, Laganà AS, Vukorepa F, Ćorić M. Mikuš M, et al. Pharmaceuticals (Basel). 2023 Sep 18;16(9):1315. doi: 10.3390/ph16091315. Pharmaceuticals (Basel). 2023. PMID: 37765123 Free PMC article. Review.
Bisindolylmaleimide IX: A novel anti-SARS-CoV2 agent targeting viral main protease 3CLpro demonstrated by virtual screening pipeline and in-vitro validation assays.
Gupta Y, Maciorowski D, Zak SE, Jones KA, Kathayat RS, Azizi SA, Mathur R, Pearce CM, Ilc DJ, Husein H, Herbert AS, Bharti A, Rathi B, Durvasula R, Becker DP, Dickinson BC, Dye JM, Kempaiah P. Gupta Y, et al. Methods. 2021 Nov;195:57-71. doi: 10.1016/j.ymeth.2021.01.003. Epub 2021 Jan 14. Methods. 2021. PMID: 33453392 Free PMC article.
Letrozole : in postmenopausal hormone-responsive early-stage breast cancer.
Scott LJ, Keam SJ. Scott LJ, et al. Drugs. 2006;66(3):353-62. doi: 10.2165/00003495-200666030-00010. Drugs. 2006. PMID: 16526826 Review.

References

1. J Clin Oncol. 2000 Nov 15;18(22):3748-57 - PubMed
1. J Clin Oncol. 2000 Apr;18(7):1399-411 - PubMed
1. Clin Cancer Res. 1999 Sep;5(9):2338-43 - PubMed
1. J Clin Oncol. 1999 May;17(5):1474-81 - PubMed
1. Cancer Chemother Pharmacol. 1990;27(2):101-5 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Springer
Other Literature Sources
- The Lens - Patent Citations Database